Bruker Announces Acquisition of Integrated Proteomics Pipeline (IP2) Software Platform for Large Cohort Translational Studies
IP2 Accelerates CCS-enabled 4D-Proteomics™ with GPU-based Scalable Search Engine IP2 Adds ‘Run & Done’ Real-Time Capabilities to timsTOF® Proteomics Systems BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) announces the recent acquisition of the Integrated Proteomics Pipeline (IP2) search engine and proteomics workflow software platform. IP2 was developed by Integrated Proteomics Applications Inc, a company founded... Read more